Norris Medicines Share Price
14.29+0.00 (+0.00%)
-15.54% past 1 Year
Norris Medicines Ltd. is one of the leading Indian manufacturers of Injections and Medicinal formulations.
Corporate filings & documents
Announcements
Outcome of the Board Meeting on Thursday 03rd September 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations 2015
18 hours agoOutcome of the Board Meeting on Thursday 03rd September 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations 2015
18 hours agoAppointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September 2026 till August 31 2029 be liable to retire by rotation.
2 weeks agoAppointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September 2026 till August 31 2029 be liable to retire by rotation.
2 weeks agoFinancial Results for the Quarter ended June 30 2026
2 weeks agoFinancial Results for the Quarter ended June 30 2026
2 weeks agoBoard Meeting held on August 14 2026 for the quarter ended June 30 2026.
2 weeks agoBoard Meeting held on August 14 2026 for the quarter ended June 30 2026.
2 weeks agoNorris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026
3 weeks agoNorris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026
3 weeks agoIntimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.
1 month agoIntimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.
1 month agoOutcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
1 month agoOutcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
1 month agoCertificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June 2026.
2 months agoCertificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June 2026.
2 months agoIntimation for Closure of Trading Window
2 months agoIntimation for Closure of Trading Window
2 months agoAppointment of Internal Auditor w.e.f 30.05.2026
3 months agoAppointment of Internal Auditor w.e.f 30.05.2026
3 months agoAs per attachment.
3 months agoAs per attachment.
3 months agoAs per attachment.
3 months agoAs per attachment.
3 months agoNorris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve As per attachment.
3 months agoNorris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve As per attachment.
3 months agoAs per attachment.
4 months agoAs per attachment.
4 months agoAs per attachment.
5 months agoAs per attachment.
5 months agoAs per attachment.
6 months agoAs per attachment.
6 months agoAs per attachment
6 months agoAs per attachment.
6 months agoAs per attachment.
6 months agoNorris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve As per attachment.
6 months agoAs per attachment.
7 months agoAs per attachment.
7 months agoAs per attachment.
8 months agoIntimation regarding Order passed by Honble High Court in Criminal Appeal No. 89 of 2020.
8 months agoAs per attachment.
9 months agoNorris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve As per attachment
9 months agoAs per attachments.
10 months agoAs per attachment.
11 months agoAs per attachment.
11 months agoAs per attachment.
11 months agoAs per attachment.
11 months agoAs per attachment.
11 months agoAs per attachment.
11 months agoAs per Attachment.
12 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Plot No. 801 / P G I D C Industrial Estate Ankleshwar Gujarat PIN: 393002 Tel No: 02646 - 223462, 227530 Fax No: 02646 - 250126 Email: [email protected] Internet: www.norrispharma.com
Registrars
Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg Gala No 9 Shiv Shakti, Industrial Estate,Sitaram Mill Comp. J R Boricha Marg, Lower Parel [E] PIN: Tel No: +91 22 4134 3255/ +91 22 4134 3256 Fax No: NULL Email: [email protected] Internet: www.purvashare.com
Management
Vimal Shah, Executive Director
A Vadivel, Non Executive Independent Director
Praveen Bafna, Non Executive Director
Priyanka Lohiya, Company Secretary
Details
BSE 524414
NSE NULL
ISIN INE744C01029